| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Services Research | 14 | 2022 | 209 | 3.190 |
Why?
|
| Workload | 6 | 2019 | 103 | 1.830 |
Why?
|
| Delivery of Health Care | 5 | 2014 | 445 | 1.520 |
Why?
|
| Persian Gulf Syndrome | 9 | 2020 | 27 | 1.510 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2022 | 157 | 1.490 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2010 | 99 | 1.460 |
Why?
|
| Veterans | 18 | 2019 | 904 | 1.430 |
Why?
|
| Gulf War | 7 | 2017 | 22 | 1.240 |
Why?
|
| Patient-Centered Care | 3 | 2022 | 106 | 1.210 |
Why?
|
| Physicians | 4 | 2012 | 324 | 1.190 |
Why?
|
| Health Services Accessibility | 10 | 2019 | 581 | 1.170 |
Why?
|
| Public Health | 2 | 2019 | 201 | 1.170 |
Why?
|
| Practice Patterns, Physicians' | 9 | 2019 | 504 | 1.040 |
Why?
|
| Quality of Health Care | 9 | 2013 | 322 | 1.040 |
Why?
|
| Humans | 144 | 2022 | 68618 | 0.950 |
Why?
|
| United States | 54 | 2022 | 7367 | 0.930 |
Why?
|
| Hospitals, Veterans | 13 | 2003 | 147 | 0.870 |
Why?
|
| Health Policy | 4 | 2019 | 221 | 0.840 |
Why?
|
| Stroke | 17 | 2009 | 2163 | 0.840 |
Why?
|
| Endarterectomy, Carotid | 11 | 2007 | 110 | 0.800 |
Why?
|
| Medicine | 2 | 2011 | 52 | 0.750 |
Why?
|
| Mobile Applications | 1 | 2022 | 138 | 0.730 |
Why?
|
| Gastrointestinal Microbiome | 5 | 2020 | 122 | 0.720 |
Why?
|
| Cerebrovascular Disorders | 8 | 1998 | 182 | 0.720 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2019 | 468 | 0.720 |
Why?
|
| Peer Review, Research | 2 | 2019 | 21 | 0.710 |
Why?
|
| Aged | 60 | 2019 | 14862 | 0.690 |
Why?
|
| Oncologists | 1 | 2019 | 9 | 0.680 |
Why?
|
| Social Work | 1 | 2019 | 27 | 0.660 |
Why?
|
| Publishing | 2 | 2019 | 89 | 0.650 |
Why?
|
| Medical Oncology | 1 | 2019 | 110 | 0.630 |
Why?
|
| Periodicals as Topic | 3 | 2019 | 158 | 0.630 |
Why?
|
| Community Health Services | 1 | 2019 | 141 | 0.620 |
Why?
|
| Activities of Daily Living | 8 | 2004 | 319 | 0.580 |
Why?
|
| Male | 86 | 2019 | 37321 | 0.580 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 36 | 0.570 |
Why?
|
| Cohort Studies | 22 | 2008 | 2358 | 0.550 |
Why?
|
| Stroke Rehabilitation | 8 | 2004 | 335 | 0.540 |
Why?
|
| Prostatic Neoplasms | 5 | 2017 | 778 | 0.530 |
Why?
|
| Female | 76 | 2021 | 38074 | 0.510 |
Why?
|
| Home Care Services | 1 | 2016 | 84 | 0.500 |
Why?
|
| Middle Aged | 52 | 2019 | 21147 | 0.500 |
Why?
|
| Continuity of Patient Care | 2 | 2016 | 170 | 0.500 |
Why?
|
| Awareness | 2 | 2014 | 81 | 0.500 |
Why?
|
| Telemedicine | 1 | 2022 | 700 | 0.480 |
Why?
|
| Adult | 45 | 2019 | 21403 | 0.470 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 235 | 0.470 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 438 | 0.460 |
Why?
|
| Health Services Administration | 1 | 2013 | 11 | 0.460 |
Why?
|
| Research Personnel | 1 | 2014 | 83 | 0.450 |
Why?
|
| Primary Health Care | 4 | 2013 | 703 | 0.440 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2004 | 240 | 0.440 |
Why?
|
| Severity of Illness Index | 12 | 2004 | 1851 | 0.440 |
Why?
|
| Neurology | 3 | 2011 | 43 | 0.440 |
Why?
|
| Pneumonia, Pneumocystis | 7 | 1998 | 57 | 0.440 |
Why?
|
| Capitation Fee | 1 | 2012 | 4 | 0.420 |
Why?
|
| Military Personnel | 6 | 2012 | 221 | 0.420 |
Why?
|
| Consumer Behavior | 1 | 2012 | 68 | 0.410 |
Why?
|
| Physicians, Family | 6 | 2011 | 83 | 0.410 |
Why?
|
| Risk Adjustment | 1 | 2012 | 49 | 0.410 |
Why?
|
| Attitude to Health | 5 | 2007 | 403 | 0.390 |
Why?
|
| Family Practice | 9 | 1995 | 312 | 0.390 |
Why?
|
| Practice Management, Medical | 4 | 2012 | 24 | 0.390 |
Why?
|
| Cultural Diversity | 2 | 2009 | 67 | 0.390 |
Why?
|
| Health Personnel | 2 | 2021 | 286 | 0.380 |
Why?
|
| Precision Medicine | 1 | 2012 | 111 | 0.380 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 2279 | 0.370 |
Why?
|
| AIDS-Related Opportunistic Infections | 5 | 1998 | 85 | 0.360 |
Why?
|
| Inpatients | 4 | 2018 | 208 | 0.330 |
Why?
|
| Patient Care | 1 | 2009 | 61 | 0.330 |
Why?
|
| North Carolina | 14 | 2004 | 224 | 0.330 |
Why?
|
| Papanicolaou Test | 2 | 2019 | 54 | 0.330 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 142 | 0.330 |
Why?
|
| Motivation | 3 | 2012 | 561 | 0.320 |
Why?
|
| Reinforcement, Social | 2 | 2007 | 7 | 0.310 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 83 | 0.300 |
Why?
|
| Aftercare | 2 | 2012 | 114 | 0.300 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2019 | 59 | 0.300 |
Why?
|
| Spinal Cord Injuries | 3 | 1999 | 551 | 0.300 |
Why?
|
| Research Support as Topic | 1 | 2007 | 58 | 0.300 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 109 | 0.290 |
Why?
|
| Time Factors | 14 | 2012 | 4655 | 0.290 |
Why?
|
| Carotid Stenosis | 4 | 2007 | 163 | 0.280 |
Why?
|
| Fees, Medical | 3 | 1991 | 9 | 0.280 |
Why?
|
| Rural Population | 8 | 1995 | 398 | 0.270 |
Why?
|
| Mammography | 2 | 2019 | 310 | 0.270 |
Why?
|
| Health Status Disparities | 1 | 2009 | 326 | 0.270 |
Why?
|
| Culture | 1 | 2006 | 75 | 0.270 |
Why?
|
| Risk Factors | 18 | 2008 | 5731 | 0.260 |
Why?
|
| Hepatitis C | 2 | 2004 | 114 | 0.260 |
Why?
|
| Risk-Taking | 2 | 2004 | 210 | 0.260 |
Why?
|
| Research Design | 4 | 2014 | 729 | 0.250 |
Why?
|
| Dysbiosis | 3 | 2020 | 24 | 0.250 |
Why?
|
| United States Department of Veterans Affairs | 8 | 2012 | 307 | 0.250 |
Why?
|
| Behavior Therapy | 2 | 2007 | 297 | 0.250 |
Why?
|
| Occupational Diseases | 1 | 2005 | 68 | 0.250 |
Why?
|
| Drug Utilization | 3 | 2004 | 119 | 0.240 |
Why?
|
| Social Support | 1 | 2007 | 423 | 0.240 |
Why?
|
| Medicaid | 4 | 2021 | 302 | 0.240 |
Why?
|
| Social Justice | 1 | 2004 | 32 | 0.240 |
Why?
|
| Aged, 80 and over | 17 | 2018 | 4848 | 0.230 |
Why?
|
| Poverty | 2 | 2019 | 219 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2007 | 310 | 0.230 |
Why?
|
| Osteoarthritis | 1 | 2004 | 73 | 0.230 |
Why?
|
| Hospitalization | 5 | 2018 | 978 | 0.230 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2003 | 6 | 0.230 |
Why?
|
| Hepatitis B | 1 | 2004 | 42 | 0.230 |
Why?
|
| Stress, Psychological | 3 | 2019 | 824 | 0.230 |
Why?
|
| Attitude of Health Personnel | 3 | 2004 | 442 | 0.220 |
Why?
|
| Health Services | 3 | 2004 | 87 | 0.220 |
Why?
|
| Retrospective Studies | 16 | 2018 | 7277 | 0.220 |
Why?
|
| Substance-Related Disorders | 4 | 2012 | 1242 | 0.220 |
Why?
|
| Warfare | 1 | 2003 | 58 | 0.220 |
Why?
|
| Blood Banks | 1 | 2002 | 6 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2005 | 269 | 0.220 |
Why?
|
| Physical Therapy Modalities | 4 | 2000 | 133 | 0.210 |
Why?
|
| Rehabilitation Centers | 1 | 2003 | 46 | 0.210 |
Why?
|
| Surveys and Questionnaires | 10 | 2017 | 2800 | 0.210 |
Why?
|
| Mental Disorders | 3 | 2012 | 659 | 0.210 |
Why?
|
| Brain Ischemia | 5 | 2003 | 665 | 0.210 |
Why?
|
| Health Services Needs and Demand | 2 | 2014 | 149 | 0.210 |
Why?
|
| Fetal Blood | 1 | 2002 | 131 | 0.210 |
Why?
|
| Epilepsy | 1 | 2006 | 336 | 0.200 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2004 | 185 | 0.200 |
Why?
|
| Mass Screening | 3 | 2019 | 843 | 0.200 |
Why?
|
| Needlestick Injuries | 1 | 2021 | 10 | 0.200 |
Why?
|
| Occupational Therapy | 4 | 2003 | 80 | 0.200 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 201 | 0.200 |
Why?
|
| Patient Credit and Collection | 2 | 1991 | 7 | 0.200 |
Why?
|
| Prospective Studies | 13 | 2012 | 3705 | 0.200 |
Why?
|
| Patient Satisfaction | 3 | 2018 | 378 | 0.200 |
Why?
|
| Registries | 4 | 2007 | 733 | 0.200 |
Why?
|
| Informed Consent | 1 | 2002 | 127 | 0.200 |
Why?
|
| Logistic Models | 9 | 2017 | 1420 | 0.190 |
Why?
|
| Dermatan Sulfate | 1 | 2001 | 12 | 0.190 |
Why?
|
| Heparitin Sulfate | 1 | 2001 | 20 | 0.190 |
Why?
|
| Insurance Coverage | 2 | 2019 | 99 | 0.190 |
Why?
|
| Health Status Indicators | 3 | 1998 | 117 | 0.190 |
Why?
|
| Prejudice | 2 | 1999 | 37 | 0.190 |
Why?
|
| Chondroitin Sulfates | 1 | 2001 | 44 | 0.190 |
Why?
|
| Physician-Patient Relations | 3 | 2011 | 261 | 0.190 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2001 | 75 | 0.180 |
Why?
|
| Keratosis | 2 | 1997 | 17 | 0.180 |
Why?
|
| Qualitative Research | 1 | 2022 | 369 | 0.180 |
Why?
|
| Polypharmacy | 1 | 2000 | 31 | 0.180 |
Why?
|
| Chronic Disease | 2 | 2017 | 1330 | 0.180 |
Why?
|
| Environment | 2 | 2012 | 115 | 0.170 |
Why?
|
| Cognition Disorders | 2 | 2004 | 342 | 0.170 |
Why?
|
| Viruses | 1 | 2019 | 14 | 0.170 |
Why?
|
| Hospitals, Urban | 2 | 1996 | 46 | 0.170 |
Why?
|
| Treatment Outcome | 12 | 2012 | 7029 | 0.170 |
Why?
|
| Faculty, Medical | 2 | 1990 | 110 | 0.170 |
Why?
|
| Remote Consultation | 1 | 1999 | 50 | 0.170 |
Why?
|
| Government Programs | 1 | 2019 | 16 | 0.170 |
Why?
|
| Dementia | 2 | 1998 | 158 | 0.170 |
Why?
|
| Social Networking | 1 | 2019 | 14 | 0.170 |
Why?
|
| Cost Sharing | 1 | 2019 | 8 | 0.170 |
Why?
|
| Bias | 2 | 2018 | 148 | 0.170 |
Why?
|
| Health Status | 6 | 2012 | 429 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2550 | 0.170 |
Why?
|
| Reproducibility of Results | 8 | 2005 | 2077 | 0.160 |
Why?
|
| Disability Evaluation | 2 | 1999 | 298 | 0.160 |
Why?
|
| Hospital Mortality | 5 | 2000 | 384 | 0.160 |
Why?
|
| Alcoholism | 1 | 2007 | 1109 | 0.160 |
Why?
|
| Medication Errors | 1 | 2000 | 116 | 0.160 |
Why?
|
| Patient Portals | 1 | 2018 | 12 | 0.160 |
Why?
|
| Gastritis | 1 | 2018 | 12 | 0.160 |
Why?
|
| Butyrates | 1 | 2018 | 14 | 0.160 |
Why?
|
| Preventive Health Services | 1 | 2019 | 86 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2001 | 356 | 0.160 |
Why?
|
| Peer Review | 1 | 2018 | 16 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2017 | 931 | 0.150 |
Why?
|
| Bacteria | 1 | 2019 | 193 | 0.150 |
Why?
|
| Coma | 1 | 1998 | 17 | 0.150 |
Why?
|
| Skin Diseases | 1 | 1999 | 122 | 0.150 |
Why?
|
| Spinal Cord Diseases | 1 | 1998 | 23 | 0.150 |
Why?
|
| Comorbidity | 7 | 2007 | 1426 | 0.150 |
Why?
|
| Stress, Physiological | 1 | 2019 | 215 | 0.150 |
Why?
|
| Incidence | 4 | 2009 | 1603 | 0.150 |
Why?
|
| Odds Ratio | 5 | 2008 | 880 | 0.150 |
Why?
|
| Inflammation | 3 | 2020 | 1030 | 0.150 |
Why?
|
| Attitude | 2 | 1998 | 121 | 0.150 |
Why?
|
| Communication | 2 | 2014 | 329 | 0.150 |
Why?
|
| Intensive Care Units | 3 | 1998 | 344 | 0.150 |
Why?
|
| Neurons | 2 | 2020 | 881 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 25 | 0.140 |
Why?
|
| Patient Admission | 1 | 1998 | 99 | 0.140 |
Why?
|
| Rehabilitation | 4 | 2001 | 29 | 0.140 |
Why?
|
| Socioeconomic Factors | 6 | 2012 | 955 | 0.140 |
Why?
|
| Minority Groups | 3 | 2006 | 197 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 1998 | 190 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 1997 | 129 | 0.140 |
Why?
|
| Multivariate Analysis | 9 | 2006 | 1046 | 0.140 |
Why?
|
| Internship and Residency | 4 | 1995 | 596 | 0.140 |
Why?
|
| Observer Variation | 5 | 2001 | 330 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 138 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2018 | 205 | 0.140 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 114 | 0.140 |
Why?
|
| Office Visits | 3 | 2011 | 83 | 0.140 |
Why?
|
| Risk | 3 | 2008 | 563 | 0.140 |
Why?
|
| Medical Audit | 2 | 2001 | 44 | 0.140 |
Why?
|
| Sexual Behavior | 2 | 1995 | 183 | 0.130 |
Why?
|
| Insurance, Hospitalization | 1 | 1995 | 6 | 0.130 |
Why?
|
| Health Resources | 1 | 1996 | 76 | 0.130 |
Why?
|
| Acute Disease | 6 | 2003 | 658 | 0.130 |
Why?
|
| Skin Neoplasms | 2 | 1997 | 375 | 0.130 |
Why?
|
| Urban Health Services | 1 | 1995 | 24 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2017 | 156 | 0.130 |
Why?
|
| Hospital Departments | 1 | 1995 | 15 | 0.130 |
Why?
|
| Data Collection | 8 | 2005 | 420 | 0.130 |
Why?
|
| Race Relations | 1 | 1995 | 1 | 0.130 |
Why?
|
| Neoplasms | 3 | 2018 | 1667 | 0.120 |
Why?
|
| Age Factors | 6 | 2005 | 1864 | 0.120 |
Why?
|
| Internal Medicine | 2 | 2011 | 118 | 0.120 |
Why?
|
| Magnesium Chloride | 1 | 1994 | 8 | 0.120 |
Why?
|
| Magnesium Deficiency | 1 | 1994 | 6 | 0.120 |
Why?
|
| Rural Health Services | 1 | 1995 | 101 | 0.120 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2004 | 73 | 0.120 |
Why?
|
| Urban Population | 2 | 1993 | 255 | 0.120 |
Why?
|
| Income | 3 | 2002 | 167 | 0.120 |
Why?
|
| HIV-1 | 1 | 1995 | 177 | 0.120 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2008 | 130 | 0.120 |
Why?
|
| Professional Practice Location | 1 | 1993 | 19 | 0.110 |
Why?
|
| Treatment Refusal | 3 | 2007 | 40 | 0.110 |
Why?
|
| Epidemiologic Methods | 5 | 2005 | 83 | 0.110 |
Why?
|
| Obesity | 1 | 2020 | 1076 | 0.110 |
Why?
|
| Geriatrics | 2 | 1996 | 69 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 51 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 1994 | 203 | 0.110 |
Why?
|
| Colorectal Surgery | 1 | 2012 | 11 | 0.110 |
Why?
|
| Alaska | 2 | 2009 | 7 | 0.100 |
Why?
|
| Adolescent Behavior | 2 | 1995 | 264 | 0.100 |
Why?
|
| Problem Solving | 1 | 1992 | 36 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2012 | 15 | 0.100 |
Why?
|
| Alcoholics Anonymous | 2 | 2012 | 13 | 0.100 |
Why?
|
| Diet Records | 1 | 1992 | 14 | 0.100 |
Why?
|
| Ambulatory Care Information Systems | 1 | 1991 | 13 | 0.100 |
Why?
|
| Residential Treatment | 2 | 2012 | 24 | 0.100 |
Why?
|
| Colonic Neoplasms | 2 | 2012 | 299 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2008 | 2007 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2016 | 413 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 1536 | 0.100 |
Why?
|
| Clinical Competence | 2 | 2012 | 657 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2002 | 767 | 0.100 |
Why?
|
| Total Quality Management | 2 | 2002 | 45 | 0.100 |
Why?
|
| Medicare | 3 | 2019 | 319 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2012 | 156 | 0.100 |
Why?
|
| Adenoma | 1 | 2012 | 132 | 0.100 |
Why?
|
| Insurance Claim Reporting | 1 | 1991 | 10 | 0.100 |
Why?
|
| Medical Records | 6 | 2000 | 121 | 0.100 |
Why?
|
| Research | 3 | 2002 | 214 | 0.100 |
Why?
|
| Pica | 1 | 1991 | 1 | 0.100 |
Why?
|
| Anthropology, Cultural | 1 | 2011 | 4 | 0.100 |
Why?
|
| Nutritional Status | 1 | 1992 | 112 | 0.090 |
Why?
|
| Private Practice | 1 | 1990 | 19 | 0.090 |
Why?
|
| General Surgery | 1 | 2011 | 95 | 0.090 |
Why?
|
| Physical Examination | 2 | 1995 | 152 | 0.090 |
Why?
|
| Sex Factors | 5 | 2003 | 1266 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1996 | 123 | 0.090 |
Why?
|
| Job Satisfaction | 1 | 2011 | 62 | 0.090 |
Why?
|
| Indians, North American | 1 | 1990 | 64 | 0.090 |
Why?
|
| Safety | 1 | 2011 | 145 | 0.090 |
Why?
|
| Health Expenditures | 1 | 2012 | 170 | 0.090 |
Why?
|
| Population Surveillance | 3 | 2008 | 285 | 0.090 |
Why?
|
| Gynecology | 1 | 1990 | 46 | 0.090 |
Why?
|
| Probability | 2 | 2008 | 245 | 0.090 |
Why?
|
| Mental Health | 1 | 2012 | 278 | 0.090 |
Why?
|
| Insurance, Health | 4 | 2019 | 201 | 0.080 |
Why?
|
| Permethrin | 2 | 2019 | 11 | 0.080 |
Why?
|
| Carotid Arteries | 3 | 2002 | 110 | 0.080 |
Why?
|
| Models, Statistical | 1 | 1992 | 448 | 0.080 |
Why?
|
| Guideline Adherence | 2 | 2002 | 287 | 0.080 |
Why?
|
| Nonprescription Drugs | 3 | 1998 | 28 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2012 | 268 | 0.080 |
Why?
|
| Pneumonia, Aspiration | 1 | 2008 | 22 | 0.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2012 | 1506 | 0.080 |
Why?
|
| Florida | 4 | 2012 | 221 | 0.080 |
Why?
|
| Community Health Centers | 1 | 1988 | 26 | 0.080 |
Why?
|
| Cough | 1 | 2008 | 65 | 0.080 |
Why?
|
| Regression Analysis | 4 | 2012 | 737 | 0.080 |
Why?
|
| Curriculum | 1 | 1992 | 575 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2003 | 714 | 0.080 |
Why?
|
| Blood Pressure | 1 | 1994 | 1451 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 1988 | 85 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2008 | 1753 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 1992 | 364 | 0.080 |
Why?
|
| Budgets | 1 | 2007 | 12 | 0.080 |
Why?
|
| Training Support | 1 | 2007 | 17 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 1991 | 286 | 0.080 |
Why?
|
| Age of Onset | 2 | 2009 | 188 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2791 | 0.070 |
Why?
|
| Temperance | 1 | 2007 | 41 | 0.070 |
Why?
|
| Organizational Culture | 1 | 2007 | 59 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 1990 | 383 | 0.070 |
Why?
|
| Hip Fractures | 2 | 1998 | 26 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 4 | 1990 | 53 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 3259 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 177 | 0.070 |
Why?
|
| Mice | 4 | 2020 | 8474 | 0.070 |
Why?
|
| Demography | 3 | 2002 | 279 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 772 | 0.070 |
Why?
|
| Internet | 3 | 2012 | 390 | 0.070 |
Why?
|
| Bronchoscopy | 3 | 1996 | 147 | 0.070 |
Why?
|
| Child Abuse, Sexual | 1 | 1987 | 150 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 2000 | 242 | 0.070 |
Why?
|
| Digestive System Neoplasms | 1 | 1985 | 13 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2007 | 1054 | 0.060 |
Why?
|
| Selection Bias | 1 | 2005 | 23 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 2 | 1999 | 167 | 0.060 |
Why?
|
| Carotid Artery Diseases | 2 | 2002 | 83 | 0.060 |
Why?
|
| Causality | 1 | 2005 | 82 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2006 | 132 | 0.060 |
Why?
|
| Patient Compliance | 2 | 2012 | 402 | 0.060 |
Why?
|
| Cytokines | 2 | 2019 | 866 | 0.060 |
Why?
|
| Military Medicine | 1 | 2005 | 53 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1994 | 1085 | 0.060 |
Why?
|
| Telephone | 2 | 2002 | 160 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 1990 | 305 | 0.060 |
Why?
|
| Hospitals, Teaching | 3 | 1996 | 65 | 0.060 |
Why?
|
| Combat Disorders | 1 | 2005 | 102 | 0.060 |
Why?
|
| Drug Prescriptions | 3 | 2008 | 135 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2019 | 1342 | 0.060 |
Why?
|
| Prognosis | 5 | 1998 | 2093 | 0.060 |
Why?
|
| Health Care Costs | 3 | 1999 | 346 | 0.060 |
Why?
|
| Anti-Ulcer Agents | 1 | 2004 | 47 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2004 | 46 | 0.060 |
Why?
|
| School Health Services | 2 | 1995 | 72 | 0.060 |
Why?
|
| International Classification of Diseases | 1 | 2004 | 85 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 73 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2004 | 41 | 0.060 |
Why?
|
| Length of Stay | 3 | 2003 | 780 | 0.060 |
Why?
|
| Suicide | 1 | 2005 | 116 | 0.060 |
Why?
|
| Indian Ocean | 1 | 2003 | 8 | 0.060 |
Why?
|
| Cognition | 2 | 1998 | 513 | 0.060 |
Why?
|
| Professional Competence | 1 | 2004 | 100 | 0.060 |
Why?
|
| Speech Therapy | 1 | 2003 | 19 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 160 | 0.060 |
Why?
|
| Adolescent | 8 | 2005 | 8912 | 0.060 |
Why?
|
| Child Abuse | 1 | 2005 | 186 | 0.060 |
Why?
|
| Quality of Life | 4 | 2007 | 1515 | 0.060 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2003 | 12 | 0.060 |
Why?
|
| Therapeutics | 1 | 2003 | 7 | 0.060 |
Why?
|
| Physical Therapy Department, Hospital | 1 | 2003 | 3 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2018 | 1692 | 0.050 |
Why?
|
| Residence Characteristics | 3 | 2000 | 252 | 0.050 |
Why?
|
| Early Detection of Cancer | 2 | 2019 | 454 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2004 | 308 | 0.050 |
Why?
|
| Blood Donors | 1 | 2002 | 18 | 0.050 |
Why?
|
| Child | 6 | 2005 | 6405 | 0.050 |
Why?
|
| Crime Victims | 1 | 2005 | 286 | 0.050 |
Why?
|
| Survival Rate | 2 | 1998 | 1056 | 0.050 |
Why?
|
| Ethics, Medical | 1 | 2002 | 86 | 0.050 |
Why?
|
| Saudi Arabia | 1 | 2021 | 7 | 0.050 |
Why?
|
| Tertiary Healthcare | 1 | 2021 | 6 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 1992 | 1173 | 0.050 |
Why?
|
| Educational Status | 1 | 2002 | 273 | 0.050 |
Why?
|
| Animals | 4 | 2020 | 20881 | 0.050 |
Why?
|
| Delphi Technique | 2 | 2001 | 62 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2021 | 191 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2002 | 191 | 0.050 |
Why?
|
| Climate | 1 | 2000 | 9 | 0.050 |
Why?
|
| Neuritis | 1 | 2020 | 4 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 2000 | 239 | 0.050 |
Why?
|
| Hepatitis | 1 | 2020 | 25 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2020 | 19 | 0.050 |
Why?
|
| Utilization Review | 2 | 1997 | 48 | 0.050 |
Why?
|
| Patient Selection | 1 | 2004 | 592 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2001 | 304 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 81 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 63 | 0.040 |
Why?
|
| Seasons | 1 | 2000 | 129 | 0.040 |
Why?
|
| Outpatients | 2 | 1991 | 127 | 0.040 |
Why?
|
| Science | 1 | 2000 | 15 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2004 | 617 | 0.040 |
Why?
|
| Pyridostigmine Bromide | 1 | 2019 | 11 | 0.040 |
Why?
|
| Boston | 1 | 2019 | 35 | 0.040 |
Why?
|
| Ribavirin | 1 | 2019 | 27 | 0.040 |
Why?
|
| Feces | 1 | 2019 | 88 | 0.040 |
Why?
|
| Physical and Rehabilitation Medicine | 1 | 1999 | 2 | 0.040 |
Why?
|
| Administrative Personnel | 1 | 2019 | 22 | 0.040 |
Why?
|
| Spine | 1 | 1999 | 46 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 1999 | 1140 | 0.040 |
Why?
|
| Los Angeles | 2 | 1995 | 30 | 0.040 |
Why?
|
| Chicago | 2 | 1995 | 30 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2019 | 79 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 1999 | 103 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2019 | 156 | 0.040 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2018 | 2 | 0.040 |
Why?
|
| Dermatology | 2 | 1997 | 75 | 0.040 |
Why?
|
| Algorithms | 2 | 2001 | 1196 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1999 | 181 | 0.040 |
Why?
|
| Biopsy | 2 | 1997 | 540 | 0.040 |
Why?
|
| Anti-Anxiety Agents | 1 | 1998 | 107 | 0.040 |
Why?
|
| Insecticides | 1 | 2018 | 43 | 0.040 |
Why?
|
| Hospitals | 2 | 1998 | 265 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 546 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 378 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2019 | 211 | 0.040 |
Why?
|
| Knowledge | 1 | 1997 | 18 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2002 | 1615 | 0.040 |
Why?
|
| Claudin-2 | 1 | 2017 | 4 | 0.040 |
Why?
|
| Endotoxemia | 1 | 2017 | 27 | 0.040 |
Why?
|
| DNA | 1 | 2019 | 597 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 1998 | 141 | 0.040 |
Why?
|
| Resuscitation Orders | 1 | 1996 | 12 | 0.030 |
Why?
|
| Pregnancy | 2 | 1994 | 2334 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2000 | 621 | 0.030 |
Why?
|
| Forecasting | 1 | 1998 | 277 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 947 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 114 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 1990 | 300 | 0.030 |
Why?
|
| Delayed-Action Preparations | 2 | 1994 | 120 | 0.030 |
Why?
|
| Health Services for the Aged | 1 | 1996 | 21 | 0.030 |
Why?
|
| Drug Utilization Review | 1 | 1996 | 19 | 0.030 |
Why?
|
| Family | 1 | 1998 | 293 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 219 | 0.030 |
Why?
|
| Transportation | 1 | 1995 | 21 | 0.030 |
Why?
|
| Health Education | 1 | 1998 | 279 | 0.030 |
Why?
|
| Transfusion Reaction | 1 | 1995 | 33 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 2 | 1997 | 329 | 0.030 |
Why?
|
| Adolescent Health Services | 1 | 1995 | 18 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1997 | 281 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2000 | 502 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2012 | 504 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1995 | 108 | 0.030 |
Why?
|
| Medical History Taking | 1 | 1995 | 94 | 0.030 |
Why?
|
| Toothbrushing | 1 | 1975 | 21 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 1991 | 2455 | 0.030 |
Why?
|
| Liver | 1 | 2020 | 1118 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 1997 | 517 | 0.030 |
Why?
|
| Arm | 1 | 1994 | 59 | 0.030 |
Why?
|
| Sex Education | 1 | 1994 | 20 | 0.030 |
Why?
|
| Abortion, Induced | 1 | 1994 | 18 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 1994 | 112 | 0.030 |
Why?
|
| Child, Preschool | 2 | 1991 | 3187 | 0.030 |
Why?
|
| Critical Illness | 1 | 1995 | 191 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1593 | 0.030 |
Why?
|
| Triglycerides | 1 | 1994 | 184 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 1975 | 114 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 1994 | 161 | 0.030 |
Why?
|
| Exercise | 1 | 1999 | 658 | 0.030 |
Why?
|
| Random Allocation | 2 | 2009 | 442 | 0.030 |
Why?
|
| Administration, Oral | 1 | 1994 | 411 | 0.030 |
Why?
|
| Leg | 1 | 1994 | 191 | 0.030 |
Why?
|
| Critical Care | 2 | 2000 | 263 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2673 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 1995 | 219 | 0.030 |
Why?
|
| Episode of Care | 1 | 1992 | 12 | 0.030 |
Why?
|
| Substance Abuse Detection | 1 | 2012 | 66 | 0.030 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2012 | 71 | 0.030 |
Why?
|
| Specialization | 1 | 2012 | 66 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2012 | 151 | 0.030 |
Why?
|
| Accreditation | 1 | 2012 | 72 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1992 | 30 | 0.030 |
Why?
|
| Colonic Polyps | 1 | 2012 | 63 | 0.030 |
Why?
|
| Financial Audit | 1 | 1991 | 3 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 1991 | 28 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 257 | 0.020 |
Why?
|
| Zinc | 1 | 1992 | 73 | 0.020 |
Why?
|
| Folic Acid | 1 | 1992 | 123 | 0.020 |
Why?
|
| Vitamin A | 1 | 1992 | 111 | 0.020 |
Why?
|
| Starch | 1 | 1991 | 18 | 0.020 |
Why?
|
| Aluminum Silicates | 1 | 1991 | 23 | 0.020 |
Why?
|
| Blood Glucose | 1 | 1994 | 631 | 0.020 |
Why?
|
| Motor Activity | 1 | 1994 | 621 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 1990 | 9 | 0.020 |
Why?
|
| Uterine Cervicitis | 1 | 1990 | 18 | 0.020 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1992 | 148 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 1990 | 22 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 1990 | 85 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 1990 | 99 | 0.020 |
Why?
|
| Physicians, Women | 1 | 1990 | 23 | 0.020 |
Why?
|
| Self Report | 1 | 2012 | 371 | 0.020 |
Why?
|
| Chlamydia Infections | 1 | 1990 | 41 | 0.020 |
Why?
|
| Theophylline | 1 | 1990 | 22 | 0.020 |
Why?
|
| Pentoxifylline | 1 | 1990 | 12 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1992 | 222 | 0.020 |
Why?
|
| Missouri | 1 | 1990 | 44 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 948 | 0.020 |
Why?
|
| Iron | 1 | 1992 | 197 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1990 | 69 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1989 | 70 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 1989 | 44 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 2324 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 1990 | 128 | 0.020 |
Why?
|
| Southeastern United States | 1 | 1990 | 281 | 0.020 |
Why?
|
| Patients | 1 | 1989 | 69 | 0.020 |
Why?
|
| Anxiety | 1 | 2012 | 422 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 1989 | 30 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 28 | 0.020 |
Why?
|
| Patient Participation | 1 | 1990 | 146 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 219 | 0.020 |
Why?
|
| Body Weight | 1 | 1990 | 554 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2008 | 55 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1989 | 163 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2008 | 152 | 0.020 |
Why?
|
| Mental Status Schedule | 2 | 1997 | 31 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 792 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2000 | 622 | 0.020 |
Why?
|
| Memory | 2 | 1998 | 214 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 186 | 0.020 |
Why?
|
| Value of Life | 1 | 1985 | 14 | 0.020 |
Why?
|
| Ohio | 1 | 1985 | 64 | 0.020 |
Why?
|
| Depression | 1 | 2012 | 943 | 0.020 |
Why?
|
| Infant | 1 | 1991 | 2891 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2005 | 33 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2008 | 297 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1985 | 75 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2005 | 392 | 0.010 |
Why?
|
| Hospitals, County | 2 | 1996 | 6 | 0.010 |
Why?
|
| Blood-Borne Pathogens | 1 | 2003 | 7 | 0.010 |
Why?
|
| Safe Sex | 1 | 2003 | 24 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2002 | 136 | 0.010 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2001 | 7 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1619 | 0.010 |
Why?
|
| Hospitals, Special | 1 | 2000 | 15 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 453 | 0.010 |
Why?
|
| Epidemiology | 1 | 2000 | 14 | 0.010 |
Why?
|
| Documentation | 1 | 2000 | 83 | 0.010 |
Why?
|
| Benchmarking | 1 | 2000 | 91 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2000 | 107 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 241 | 0.010 |
Why?
|
| Diffusion of Innovation | 1 | 2000 | 102 | 0.010 |
Why?
|
| Linear Models | 1 | 2000 | 521 | 0.010 |
Why?
|
| Half-Life | 1 | 1998 | 96 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2002 | 506 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1999 | 258 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 1998 | 130 | 0.010 |
Why?
|
| Early Ambulation | 1 | 1997 | 8 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 1990 | 800 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 1 | 1997 | 68 | 0.010 |
Why?
|
| Pharmacoepidemiology | 1 | 1996 | 1 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2002 | 807 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1996 | 80 | 0.010 |
Why?
|
| Central Nervous System Agents | 1 | 1996 | 37 | 0.010 |
Why?
|
| Homosexuality | 1 | 1995 | 10 | 0.010 |
Why?
|
| New York City | 1 | 1995 | 49 | 0.010 |
Why?
|
| Bisexuality | 1 | 1995 | 18 | 0.010 |
Why?
|
| Public Opinion | 1 | 1995 | 32 | 0.010 |
Why?
|
| Token Economy | 1 | 1975 | 12 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1995 | 249 | 0.010 |
Why?
|
| Analgesics | 1 | 1996 | 118 | 0.010 |
Why?
|
| Reflex | 1 | 1994 | 21 | 0.010 |
Why?
|
| Sensation | 1 | 1994 | 49 | 0.010 |
Why?
|
| Muscles | 1 | 1994 | 158 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1994 | 58 | 0.010 |
Why?
|
| Postural Balance | 1 | 1994 | 93 | 0.010 |
Why?
|
| Movement | 1 | 1994 | 179 | 0.010 |
Why?
|
| Angiography | 1 | 1993 | 194 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1992 | 40 | 0.010 |
Why?
|
| Health Behavior | 1 | 1995 | 458 | 0.010 |
Why?
|
| Photometry | 1 | 1990 | 6 | 0.010 |
Why?
|
| Astemizole | 1 | 1990 | 1 | 0.010 |
Why?
|
| Pain | 1 | 1994 | 472 | 0.010 |
Why?
|
| Appetite | 1 | 1990 | 16 | 0.010 |
Why?
|
| Chlamydia trachomatis | 1 | 1990 | 26 | 0.010 |
Why?
|
| Tetracycline | 1 | 1990 | 29 | 0.010 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 1990 | 22 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 852 | 0.010 |
Why?
|
| Nucleolus Organizer Region | 1 | 1990 | 2 | 0.010 |
Why?
|
| Nuclear Envelope | 1 | 1990 | 8 | 0.010 |
Why?
|
| Mitosis | 1 | 1990 | 76 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1989 | 14 | 0.010 |
Why?
|
| Chromatin | 1 | 1990 | 76 | 0.010 |
Why?
|
| Hospitals, Community | 1 | 1989 | 64 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1990 | 289 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 1989 | 91 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 507 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1990 | 1738 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1989 | 475 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 629 | 0.000 |
Why?
|